ArticleBone marrow transplantation2009
Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis.
Article in Bone marrow transplantation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Endoscopic and intrathecal management of intraventricular fungal infections: a case report of Cladophialophora bantiana and systematic review.BMC infectious diseases · 2026Pooled it
- Cerebral Aspergillosis: Diagnostic Challenges, Therapeutic Strategies, and Future Research.CNS drugs · 2026Review
- Successful Treatment of RefractoryClinical case reports · 2025Article
- The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.Frontiers in pharmacology · 2024Article
- Systemic Antifungal Therapy for Invasive Pulmonary Infections.Journal of fungi (Basel, Switzerland) · 2023Review
- Meningeal Sporotrichosis Due toJournal of fungi (Basel, Switzerland) · 2022Article
- Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system.Medical mycology · 2020Article
- Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle.Antimicrobial agents and chemotherapy · 2020Article
- Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis.Antimicrobial agents and chemotherapy · 2019Article
- Antifungal Drugs: Special Problems Treating Central Nervous System Infections.Journal of fungi (Basel, Switzerland) · 2019Article
- Central Nervous System Infection withJournal of fungi (Basel, Switzerland) · 2019Review
- Mucormycosis of the Central Nervous System.Journal of fungi (Basel, Switzerland) · 2019Review
- Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.European journal of drug metabolism and pharmacokinetics · 2019Review
- The Rise ofFrontiers in immunology · 2019Review
- Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications.Current neurology and neuroscience reports · 2018Review
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Infection · 2017Review
- Isavuconazole treatment of a patient with disseminated mucormycosis.Journal of clinical microbiology · 2014Article
- Tissue penetration of antifungal agents.Clinical microbiology reviews · 2014Review
- Reflections on the approach to treatment of a mycologic disaster.Antimicrobial agents and chemotherapy · 2013Article
- Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.Drug, healthcare and patient safety · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
19219077What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.